XM does not provide services to residents of the United States of America.

Wall Street set to fall as megacap chip, tech stocks tumble



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Wall Street set to fall as megacap chip, tech stocks tumble</title></head><body>

Chip stocks slump on China trade worries, tech rout

J&J flat after cutting annual profit forecast

Lilly down as rival Roche reports early data for obesity pill

Spirit Airlines shares slip after lowered Q2 forecast

Futures down: Dow 0.28%, S&P 500 0.96%, Nasdaq 1.46%

Updated at 8:40 a.m. Et/1240 GMT

By Lisa Pauline Mattackal and Ankika Biswas

July 17 (Reuters) - Indexes were set to open lower on Wednesday, as declines in major chip and tech stocks led broad-based market losses amid a slew of corporate results and the prospect of tougher U.S. trade restrictions being imposed on Chinese chips.

A report that theBiden Administration was considering severetrade restrictions as part of a chip clampdown against China weighed on semiconductor stocks in premarket trading.

AI-chip favorite Nvidia NVDA.O tumbled3.8%, while ASML's U.S.-listing ASML.O lost8.2%.

In other moves, U.S.-listed shares of Taiwan Semiconductor Manufacturing TSM.N shed6.0% after Republican presidential candidate Donald Trump said Taiwan should pay the U.S. for its defense.

Marvell Technology MRVL.O, Broadcom AVGO.O, Qualcomm QCOM.O, Micron Technology MU.O, Advanced Micro Devices AMD.O and Arm Holdings ARM.O were also down between 3% and 4.7%.

All the so-called "Magnificent Seven" megacap stocks slumped, with Apple AAPL.O, Microsoft MSFT.O Meta Platforms META.O and Tesla TSLA.O down between 1% and 2.1%.

The possibility of a fresh crackdown on China trade could be the negative trigger investors were waiting for to start booking profits in tech stocks, according to Ahmed Azzar, financial market analyst at Equiti Group.

Futures tracking the Russell 2000 RTYcv1 fell0.6% after the small-cap index .RUT rallied nearly 12% over the last five sessions.

Signaling growing investor unease,Wall Street's "fear gauge" .VIX was trading at its highest level in six weeks.

The Dow Jones Industrial Average .DJI and the S&P 500 .SPX had closed at all-time highs on Tuesday.

After a blistering rally in tech companies since the last leg of 2023, investors have begun moving out of expensive megacaps to underperforming areas of the market.

"I'm still optimistic that the market is not as expensive as maybe it's feared, but that's because we're so overbought that some near-term selling pressure is likely to develop," said Robert Pavlik, senior portfolio manager at Dakota Wealth, adding that he had also taken some profits in tech.

Firmer bets on a Fed rate cut in September as well as rising expectations that former President Donald Trump will be back in the White House in November following theattempt on his life havehelped lift stocks in the last few sessions.

Investors will focus on comments from Fed officials Thomas Barkin and Christopher Waller later in the day for clues on how policymakers have assessed recent economic data.

The New York Fed's John Williams said in an interview that the central bank was "getting closer" to a point where it could start cutting interest rates.

On the earnings front, J&J JNJ.N was flat, paring losses after the drug and devices maker lowered itsannual earnings forecast.

Industrial production data for June is also due before markets open.

At 8:40 a.m. ET, Dow e-minis 1YMcv1 were down 116 points, or 0.28%, S&P 500 e-minis EScv1 were down 55 points, or 0.96%, and Nasdaq 100 e-minis NQcv1 were down 300.75 points, or 1.46%.

Among others, U.S. drugmaker Eli Lilly LLY.N fell 3.4% after Swiss rival Roche's ROG.S promising early-stage data from anexperimental obesity pill.

Spirit Airlines SAVE.N slumped 4%after lowering its second-quarter revenue outlook, citing lower-than-expected non-ticket revenue.

Northern Trust NTRS.O rose 2.1% after the asset and wealth manager reported a jump in second-quarter profit on higher fees and an accounting gain.



Reporting by Lisa Mattackal and Ankika Biswas in Bengaluru; Editing by Pooja Desai

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.